106 related articles for article (PubMed ID: 3199662)
1. [Effect of the beta-blocker propranolol (obzidan) on the content of macroergic phosphates and the development of the size of necrotic areas in the myocardium in experimental acute coronary occlusion].
Irgashev ShB; Mavridi DI; Iuldashev NM
Kardiologiia; 1988 Aug; 28(8):86-90. PubMed ID: 3199662
[TBL] [Abstract][Full Text] [Related]
2. [Effect of obzidan on the adenine nucleotide content of various areas of the heart in experimental myocardial infarct].
Irgashev ShB; Iuldashev NM
Farmakol Toksikol; 1987; 50(1):44-5. PubMed ID: 3556552
[TBL] [Abstract][Full Text] [Related]
3. [Effect of hypercholesterolemia on the macroergic content and size of necrotic area in the heart muscle in acute coronary occlusion in rabbits].
Irgashev ShB; Iuldashev NM
Patol Fiziol Eksp Ter; 1987; (3):62-4. PubMed ID: 3627838
[No Abstract] [Full Text] [Related]
4. [Effect of prolonged beta-adrenergic blockade on myocardial energy metabolism in coronary occlusion].
Sysoliatina NA
Farmakol Toksikol; 1982; 45(4):41-6. PubMed ID: 7128783
[TBL] [Abstract][Full Text] [Related]
5. [Obzidan inhibition of lipid free-radical peroxidation in coronary-occluding myocardial infarct].
Luk'ianova LO; Kudrin AN; Kogan AKh
Farmakol Toksikol; 1983; 46(1):45-8. PubMed ID: 6825817
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the effectiveness of the long-term use of obzidan in experimental myocardial infarct].
Zufarov KA; Irgashev ShB; Azizov KN
Biull Eksp Biol Med; 1984 Jul; 98(7):53-6. PubMed ID: 6466831
[TBL] [Abstract][Full Text] [Related]
7. [Morphological criteria of the effectiveness of using kordaron and obzidan in experimental myocardial ischemia].
Grigor'eva NN; Gichka SG; Stepaniuk GI; Degtiareva LV
Vrach Delo; 1984 Oct; (10):91-3. PubMed ID: 6516320
[No Abstract] [Full Text] [Related]
8. [Experimental myocardial infarction in atherosclerosis--various methods of pharmacological correction].
Irgashev ShB
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):50-7. PubMed ID: 4005054
[TBL] [Abstract][Full Text] [Related]
9. [The cardioprotective action of carnitine and its structural analog 3-(2,2,2-trimethylhydrazine)propionate on cardiac energy metabolism in experimental occlusion of the coronary artery in rats].
Ratunova TM; Bauman VR; Kalvin'sh IIa
Farmakol Toksikol; 1989; 52(5):24-7. PubMed ID: 2599072
[TBL] [Abstract][Full Text] [Related]
10. [Effect of nonachlazine on the size of an experimental myocardial infarct].
Gatsura SV; Cherpachenko NM; Turilova AI; Afonskaia NI; Pozonov IuB
Biull Eksp Biol Med; 1984 May; 97(5):574-6. PubMed ID: 6722335
[TBL] [Abstract][Full Text] [Related]
11. Participation of the vasodilating property of nipradilol in improving ischemic derangement of myocardial energy metabolism.
Higuchi M
J Cardiovasc Pharmacol; 1989 Jul; 14(1):157-65. PubMed ID: 2475707
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of the protective action of ethacizin on the ischemic myocardium].
Kaverina NV; Gatsura SV; Turilova AI
Biull Eksp Biol Med; 1984 Sep; 98(9):315-7. PubMed ID: 6386068
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion.
Maroko PR; Libby P; Sobel BE; Bloor CM; Sybers HD; Shell WE; Covell JW; Braunwald E
Circulation; 1972 Jun; 45(6):1160-75. PubMed ID: 5032816
[No Abstract] [Full Text] [Related]
14. Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart.
Lubbe WF; Muller CA; Worthington M; McFadyen EL; Opie LH
Cardiovasc Res; 1981 Dec; 15(12):690-9. PubMed ID: 6275992
[TBL] [Abstract][Full Text] [Related]
15. [Morphological bases of the effect of verapamil on the heart in experimental acute coronary failure].
Tereshchenko VP; Nizhenkovskaia IV
Vrach Delo; 1983 May; (5):19-21. PubMed ID: 6880160
[No Abstract] [Full Text] [Related]
16. Infarct size reduction by propranolol before and after coronary ligation in dogs.
Rasmussen MM; Reimer KA; Kloner RA; Jennings RB
Circulation; 1977 Nov; 56(5):794-8. PubMed ID: 912840
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
Willerson JT; Buja LM
Am J Cardiol; 1984 Dec; 54(11):16E-20E. PubMed ID: 6150632
[TBL] [Abstract][Full Text] [Related]
18. [Definition and significance of the area at risk in myocardial infarct and the ischemic border zone in acute myocardial infarct].
Glogar DH
Acta Med Austriaca Suppl; 1986; 36():1-40. PubMed ID: 3475927
[TBL] [Abstract][Full Text] [Related]
19. [Intracellular mechanisms of the effect of cytochrome C on various areas of the myocardium during the dynamic development of an experimental infarct].
Irgashev ShB; Iuldashev NM
Farmakol Toksikol; 1988; 51(5):41-4. PubMed ID: 2850220
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of KW-3049, a new 1,4-dihydropyridine calcium antagonist, on the reduction of myocardial creatine kinase activity and high-energy phosphate content in rats subjected to coronary artery ligation.
Karasawa A; Kubo K
J Pharmacobiodyn; 1988 Nov; 11(11):722-9. PubMed ID: 3236204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
